within Pharmacolibrary.Drugs.ATC.D;

model D05BA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D05BA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bergapten (5-methoxypsoralen) is a furocoumarin compound primarily found in bergamot and other citrus oils. Historically, it has been used as a photosensitizing agent in the treatment of skin disorders such as psoriasis and vitiligo in combination with UVA phototherapy (PUVA therapy). It is not widely approved for systemic use as a drug today due to safety concerns, particularly phototoxicity and carcinogenicity risks.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults administered bergapten orally. No specific clinical pharmacokinetic data for bergapten as a drug in humans found in published studies.</p><h4>References</h4><ol><li><p>Xu, J, et al., &amp; Wang, S (2023). Effects of bergapten on the pharmacokinetics of macitentan in rats both . <i>Frontiers in pharmacology</i> 14 1204649–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2023.1204649&quot;>10.3389/fphar.2023.1204649</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37492094/&quot;>https://pubmed.ncbi.nlm.nih.gov/37492094</a></p></li><li><p>Yu, XA, et al., &amp; Chang, YX (2016). The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detection. <i>Chemistry Central journal</i> 10 62–None. DOI:<a href=&quot;https://doi.org/10.1186/s13065-016-0212-x&quot;>10.1186/s13065-016-0212-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27795734/&quot;>https://pubmed.ncbi.nlm.nih.gov/27795734</a></p></li><li><p>Qu, G, et al., &amp; Gou, Q (2018). Pharmacokinetics of Sijunzi decoction in rat plasma after oral administration using ultra-high-performance liquid chromatography electrospray ionization quadrupole-time of flight mass spectrometry. <i>Biomedical chromatography : BMC</i> 32(11) e4334–None. DOI:<a href=&quot;https://doi.org/10.1002/bmc.4334&quot;>10.1002/bmc.4334</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29993133/&quot;>https://pubmed.ncbi.nlm.nih.gov/29993133</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D05BA03;
